Shares of ResMed Inc. RMD slipped 2.47% to $220.22 Wednesday, on what proved to be an all-around mixed trading session for ...

Resmed, a leader in sleep technology, unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters. To help ...

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

Resmed RMD has unveiled a comprehensive brand evolution to lead the global sleep and health technology revolution. The strategy unifies all Resmed brands under a single health technology brand, aiming ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

At the forefront of this revolution are players like NVIDIA, whose AI computing platforms are accelerating AI-powered medical ...

Sleep technology company Resmed has launched a new global campaign, enlisting the help of a ‘sleep monster’ developed by local creative agency partner Hopeful Monsters.The latest consumer health ...

Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...

Resmed, a leader in sleep technology, has unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters.